These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 19300372)

  • 1. Oral bisphosphonates-associated osteonecrosis in rheumatoid arthritis.
    Junquera L; Gallego L; Pelaz A; Olay S
    Med Oral Patol Oral Cir Bucal; 2009 Jun; 14(6):E292-4. PubMed ID: 19300372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
    Grant BT; Amenedo C; Freeman K; Kraut RA
    J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
    Assael LA
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy.
    Migliorati CA; Schubert MM; Peterson DE; Seneda LM
    Cancer; 2005 Jul; 104(1):83-93. PubMed ID: 15929121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.
    Friedrich RE; Blake FA
    Anticancer Res; 2007; 27(4A):1841-5. PubMed ID: 17649782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
    Grewal VS; Fayans EP
    Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Osteonecrosis of the mandible induced by intravenous bisphosphonates in oncological patients].
    Carvalho A; Amaral Mendes R; Carvalho D; Carvalho JF
    Acta Med Port; 2008; 21(5):505-10. PubMed ID: 19187694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Osteonecrosis of the jaws and bisphosphonates].
    Junod AF; Carrel JP; Richter M; Vogt-Ferrier N
    Rev Med Suisse; 2005 Nov; 1(39):2537-40, 2542-3. PubMed ID: 16323736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteonecrosis of the jaws in patients treated with bisphosphonates. Review of the literature and the Milan experience.
    Oltolina A; Achilli A; Lodi G; Demarosi F; Sardella A
    Minerva Stomatol; 2005; 54(7-8):441-8. PubMed ID: 16211002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates.
    Farrugia MC; Summerlin DJ; Krowiak E; Huntley T; Freeman S; Borrowdale R; Tomich C
    Laryngoscope; 2006 Jan; 116(1):115-20. PubMed ID: 16481822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
    Carlson ER; Basile JD
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonate-induced osteonecrosis of the jaw: a medical enigma?
    Siddiqi A; Payne AG; Zafar S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):e1-8. PubMed ID: 19570696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate osteonecrosis of the jaws; an increasing problem for the dental practitioner.
    McLeod NM; Davies BJ; Brennan PA
    Br Dent J; 2007 Dec; 203(11):641-4. PubMed ID: 18065983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maxilla osseus sequestre and oral exposure: effects of the treatment of multiple myeloma with bisphosphonates.
    Lobato JV; Rodrigues JM; Cavaleiro MV; Lobato JM; Xavier L; Santos JD; Maurício AC
    Acta Med Port; 2007; 20(2):185-92. PubMed ID: 17868526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates and oral pathology II. Osteonecrosis of the jaws: review of the literature before 2005.
    Estefanía Fresco R; Ponte Fernández R; Aguirre Urizar JM
    Med Oral Patol Oral Cir Bucal; 2006 Nov; 11(6):E456-61. PubMed ID: 17072246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteonecrosis of the jaws associated with use of risedronate: report of 2 new cases.
    Brooks JK; Gilson AJ; Sindler AJ; Ashman SG; Schwartz KG; Nikitakis NG
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Jun; 103(6):780-6. PubMed ID: 17223592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases.
    Alons K; Kuijpers SC; de Jong E; van Merkesteyn JP
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Feb; 107(2):e1-7. PubMed ID: 19071040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonate associated osteonecrosis: an unusual case.
    Mehanna P; Goddard R
    Aust Dent J; 2010 Sep; 55(3):311-3. PubMed ID: 20887520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteonecrosis of the jaw: balancing the benefits and risks of oral bisphosphonate treatment for osteoporosis.
    Jeffcoat M; Watts NB
    Gen Dent; 2008; 56(1):96-102; quiz 103-4, 111-2. PubMed ID: 18254568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonate-related osteonecrosis of the jaws (ONJ): a report of two cases.
    Pongchaiyakul C; Auraiwan K; Kotruchin P; Kularbkaew C
    J Med Assoc Thai; 2007 Nov; 90(11):2494-8. PubMed ID: 18181340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.